Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL10965108 | 0.95 | — | — | |
| Pyridine SCHEMBL30336469 | 0.95 | — | — | |
| Pyridine SCHEMBL30320033 | 0.90 | TP53 (0.30) | TP53TSHR | |
| Pyridine SCHEMBL31579081 | 0.90 | — | — | |
| Pyridine SCHEMBL30718930 | 0.90 | — | — | |
| Pyridine SCHEMBL29384311 | 0.90 | — | — | |
| Pyridine SCHEMBL16702934 | 0.90 | TP53 (0.30) | TP53TSHR | |
| Pyridine SCHEMBL31757303 | 0.90 | TP53 (0.30) | TP53TSHR | |
| Pyridine SCHEMBL11087275 | 0.90 | TP53 (0.30) | TP53TSHR | |
| Pyridine SCHEMBL9622112 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111875581-A | Indolylpyridine oxide salt with novel structure and preparation method and application thereof | 河南大学 | 2020-11-03 | — | — | CN | disclosed |
| US-9133128-B2 | Pyrazole derivatives as cannabinoid receptor 1 antagonists | RESEARCH TRIANGLE INSTITUTE (US) | 2015-09-15 | — | — | US | disclosed |
| US-20140107157-A1 | PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR 1 ANTAGONISTS | RESEARCH TRIANGLE INSTITUTE (US) | 2014-04-17 | — | — | US | disclosed |
| WO-2012174362-A1 | PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR 1 ANTAGONISTS | RESEARCH TRIANGLE INSTITUTE (US) | 2012-12-20 | — | — | WO | disclosed |
| EP-2399885-A1 | Device and method for solubilizing, separating, removing and reacting carboxylic acids in aqueous or organic solutions by means of micro- or nanoemulsification | Dietz, Ulrich (DE) | 2011-12-28 | — | — | EP | disclosed |
| US-20080234271-A1 | Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them | ICOS CORPORATION (US) | 2008-09-25 | — | — | US | disclosed |
| US-20070259863-A1 | Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives | ICOS CORPORATION (US) | 2007-11-08 | — | — | US | disclosed |
| US-20070066585-A1 | ARYL PHENYLHETEROCYCLYL SULFIDE DERIVATIVES AND THEIR USE AS CELL ADHESION-INHIBITING ANTI-INFLAMMATORY AND IMMUNE-SUPPRESSIVE AGENTS | WANG GARY T | 2007-03-22 | — | — | US | disclosed |
| EP-1740561-A2 | ARYLPHENYLAMINO-AND ARYLPHENYLETHER-SULFIDE DERIVATIVES, USEFUL FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ICOS Corporation (US) | 2007-01-10 | — | — | EP | disclosed |
| EP-1740565-A2 | ARYLPHENYLAMINO-, ARYLPHENYLAMIDE-, AND ARYLPHENYLETHER-SUFIDE DERIVATIVES | ICOS Corporation (US) | 2007-01-10 | — | — | EP | disclosed |
| US-6013795-A | Alpha-branched fluoroalkylcarbonyl fluorides and their derivatives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-01-11 | — | — | US | disclosed |
| US-5998521-A | CONTAINING A BRANCHED FLUOROALKYLCARBONYL COMPOUND AS EMULSIFIER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0937027-A1 | ALPHA-BRANCHED FLUOROALKYLCARBONYL FLUORIDES AND THEIR DERIVATIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-08-25 | — | — | EP | disclosed |
| EP-0935486-A1 | AQUEOUS FILM-FORMING FOAM COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-08-18 | — | — | EP | disclosed |
| EP-0935621-A1 | AQUEOUS FLUOROPOLYMER COMPOSITIONS AND METHOD OF PREPARING THE SAME | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-08-18 | — | — | EP | disclosed |
| WO-1998020055-A1 | AQUEOUS FLUOROPOLYMER COMPOSITIONS AND METHOD OF PREPARING THE SAME | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-14 | — | — | WO | disclosed |
| WO-1998019988-A1 | ALPHA-BRANCHED FLUOROALKYLCARBONYL FLUORIDES AND THEIR DERIVATIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-14 | — | — | WO | disclosed |
| WO-1998019742-A1 | AQUEOUS FILM-FORMING FOAM COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-14 | — | — | WO | disclosed |
| EP-0075335-B1 | PROCESS FOR THE CO-PRODUCTION OF CARBOXYLIC ACIDS AND CARBOXYLIC ACID ESTERS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1985-10-23 | — | — | EP | disclosed |
| EP-0075335-A1 | Process for the co-production of carboxylic acids and carboxylic acid esters | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1983-03-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107157-A1 | PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR 1 ANTAGONISTS | CNR1, CNR2, GPR119 | TP53 4461/4885TSHR 1253/4885 |
| US-20070259863-A1 | Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives | AHR, ARSA, TST | TP53 2271/4885TSHR 3012/4885 |
| US-20080234271-A1 | Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them | HPGDS, AHR, TST | TP53 2424/4885TSHR 2954/4885 |
| US-20070066585-A1 | ARYL PHENYLHETEROCYCLYL SULFIDE DERIVATIVES AND THEIR USE AS CELL ADHESION-INHIBITING ANTI-INFLAMMATORY AND IMMUNE-SUPPRESSIVE AGENTS | VCAM1, ICAM1, CD47 | TP53 3533/4885TSHR 3676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.